Cymbet EnerChip Solid State Batteries Verified 100 Percent Biocompatible

Cymbet Corporation announced at the PCIM Europe show the successful results of in vivo biocompatibility feasibility studies that were conducted to evaluate the biological safety of the EnerChip Rechargeable Solid State Battery. EnerChip bare die batteries were crushed and combined into a saline solution, which was introduced into an in vivo test setting. No ill effects were recorded nor were any test article related lesions observed in this study.

These in vivo test results reinforce similar findings from Cymbet’s July 2012 in vitro studies, in which EnerChip bare die battery samples were gamma sterilized and evaluated using two in vitro test methods for cytotoxicity and the EnerChips demonstrated 100% non-cytotoxicity.

Cymbet EnerChip solid state batteries are uniquely fabricated using standard semiconductor manufacturing processes using patented construction techniques. One of the most rigorous ways to test the intrinsic biological safety of the EnerChip battery is to introduce crushed EnerChip bare die into in vivo test settings. Crushing the battery replicates the case of an EnerChip-powered implanted medical device that is catastrophically destroyed. In this trauma situation, the EnerChip battery components would be exposed directly to the in vivo setting. The results of this in vivo testing showed no harmful effects from having the crushed EnerChips in the body.